“We didn’t know what to expect when we launched, and it was such an incredible surprise when we raised the $150,000 so quickly. “That was such an exciting night for all of us,” says Yumeng Cheng, Head of Branding at Jingling. When JingPad launched on Indiegogo earlier this year, it raised just under $150,000 in just 15 minutes, validating the market for a consumer-grade Linux tablet. As a Linux-based tablet, it’s fully open source, so users can tinker with nearly any part of the operating system.Īnd Jingling’s hunch around market demand has proven correct.
JING LING UMKC ANDROID
It brings all the best aspects of iOS and Android tablets - a large display, top-tier computing power, sleek design - and adds an additional layer of customizability. The Jingpad A1 is the world’s first consumer-level Linux tablet, built around the concept of open-source operating systems and software. The world’s first consumer-oriented, open-source tablet When he posted his observation on Reddit, he received 73 comments in a single day, which piqued his interest.Īfter doing some deeper market analysis within the Linux community, he discovered that no consumer-grade Linux tablets existed on the market, so he saw an opportunity. The story of JingPad begins three years ago when Jingling’s CEO noticed there was a gap in the consumer-level Linux tablet market.
Their concept has gained so much traction, in fact, that the team recently secured $10 million in seed funding from prominent Venture Capital firm Sinovation. Jingling recently launched their first Linux tablet on Indiegogo, the Jingpad A1, which raised nearly $150,000 in a matter of minutes, proving the deep market for Linux-based tablets. Jingling is on a mission to change the tablet landscape by offering a third option - a consumer-grade Linux tablet - that makes no compromises. So, if tablets are so handy, why do consumers only have a choice between iOS and Android operating systems?
JING LING UMKC PORTABLE
John A.The worldwide popularity of tablet computers is on the rise, and it’s not hard to see why: they’re lightweight, they connect to the internet nearly anywhere, and they make excellent portable entertainment systems. Jing Li, Senior Vice President, WuXi Biologics, China Jean-Denis Docquier, Associate Professor, Department of Medical Biotechnology, University of Siena, Italy Hong Ling, CSO and Head of Clinical Research, Sanhome Pharmaceutical Co., Ltd., USA Hassan Hemeg, Assistant Professor, Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, KSA Qun (Max) Dang, Corporate Vice President, CSPC PHARMA LTD, China
George Kokotos, Professor of Organic and Medicinal Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Greece Gavin Stewart DAWE, Associate Professor, National University of Singapore, Singapore Lee, Professor, UMKC School of Pharmacy, USAĭong Liang, President&CEO, Aurora Biomed Inc., Canadaįeng Qian, Professor and Vice Dean, School of Pharmaceutical Sciences, Tsinghua University, Chinaįrederique Ponchel, Associate Professor, Head of Translational Research in Immune Mediated Inflammatory Diseases, The University of Leeds, UK Heard, Reader in Pharmaceutical Chemistry, School of Pharmacy & Pharmaceutical Sciences, CITER, Research Committee Chair, Cardiff University, UKĬhi H. Edvard SMITH, Professor, Karolinska Institutet, SwedenĬhang-Deng Hu, Professor and Showalter University Scholar, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, USAĬharles M. International Scientific Advisory Broad Membersīalazs Sarkadi, Research Professor, Semmelweis University；Hungarian Academy of Sciences, Head of Membrane Biology Research Group, HungaryĬ. Chong-Su Cho, Fellow of Korean Academy of Science and Technology, Fellow of International Union of Societies for Biomaterials Science and Engineering Research Professor, Research Institute for Agriculture and Life Sciences, Seoul National University, South Korea
0 kommentar(er)
